Dechra Pharmaceuticals PLC (DPH)

5,130.0
+154.0(+3.10%)
  • Volume:
    1,433,642
  • Bid/Ask:
    0.0/0.0
  • Day's Range:
    5,000.0 - 5,135.0

DPH Overview

Prev. Close
4,976
Day's Range
5,000-5,135
Revenue
874.6M
Open
5,015
52 wk Range
3,110-5,525
EPS
0.51
Volume
1,433,642
Market Cap
5.55B
Dividend (Yield)
40.50
(0.81%)
Average Volume (3m)
235,948
P/E Ratio
100.53
Beta
0.54
1-Year Change
57.36%
Shares Outstanding
108,217,639
Next Earnings Date
21 Feb 2022
What is your sentiment on Dechra Pharmaceuticals PLC?
or
Market is currently closed. Voting is open during market hours.

Dechra Pharmaceuticals PLC News

Dechra Pharmaceuticals PLC Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy

Dechra Pharmaceuticals PLC Company Profile

Dechra Pharmaceuticals PLC Company Profile

Employees
0

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. The company operates in the United Kingdom, Germany, rest of Europe, the United States, and internationally. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.